Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05432986 · ClinicalTrials.gov registry record

Assessment of CSF Shunt Flow With Thermal Measurements B

A clinical trial of Hydrocephalus, sponsored by Rhaeos.

Completed
Registry status
141
Enrollment target
10
Study locations

NCT05432986 is a study of Hydrocephalus that has completed, run by Rhaeos. The registered enrollment target is 141 participants, above the 125-participant average among 17 other Hydrocephalus trials with a reported enrollment target (13% higher). The trial reports 10 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05432986, a study of Hydrocephalus, has completed, sponsored by Rhaeos.

COMPLETED
Registry status
141 participants
Enrollment target
10
Study locations

Study Summary

This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.

Conditions Studied

Interventions

  • DEVICE Thermal Anisotropy Measurement Device

Study Locations (10)

Illinois

  • Lurie Children's Hospital - Chicago
  • Northwestern Memorial Hospital - Chicago
  • University of Illinois Chicago - Chicago

California

  • UCSF Benioff Children's Hospital - Oakland
  • UCSF Benioff Children's Hospital - San Francisco

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati
  • Dayton Children's Hospital - Dayton

Missouri

  • Washington University in St. Louis - St Louis

New York

  • Lenox Hill Hospital - New York

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 141 participants
Start Date 2022-07-07
Est. Completion 2023-11-10

Sponsor

Rhaeos

15 total trials

What the Registry Record Tells You About NCT05432986

The ClinicalTrials.gov registry entry for NCT05432986 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 125-participant average among 17 other Hydrocephalus trials with a reported enrollment target (13% higher). The listed sponsor is Rhaeos, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which Thermal Anisotropy Measurement Device is the first listed.

NCT05432986 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Illinois, California, Ohio.

Frequently Asked Questions

What is clinical trial NCT05432986 about?

NCT05432986 is a clinical study titled "Assessment of CSF Shunt Flow With Thermal Measurements B". This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.

What is the current status of trial NCT05432986?

This trial is currently completed. The enrollment target is 141 participants. The study started on 2022-07-07. Estimated completion is 2023-11-10.

What conditions does trial NCT05432986 study?

This clinical trial studies the following conditions: Hydrocephalus.

What interventions are being tested in trial NCT05432986?

The interventions under investigation include: Thermal Anisotropy Measurement Device (DEVICE).

Who is sponsoring clinical trial NCT05432986?

This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05432986 being conducted?

This trial has 10 study locations across California, Illinois, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hydrocephalus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.